Internal Medicine, Rheumatology · Glastonbury, CT
NPI
1417147406
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
223 Addison Rd Ste 304
Glastonbury, CT, 06033
Phone (860) 246-4260
Groups this clinician bills Medicare through
Medicare paid, 2024
$607K
59,738 services
Medicare patients, 2024
291
Average age 77
Drug cost, 2024
$3.0M
3,620 prescriptions
Company payments, 2025
$3,737
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Vischio was code J1602 (injection, golimumab, 1 mg, for intravenous use), 9,950 times for 15 patients. In total John Vischio billed 59,738 services in 65 codes, and Medicare paid $607K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,950 | 15 | $9.09 | $90K |
| J0897 Injection, denosumab, 1 mg | Office | 1,023 | 13 | $20.63 | $21K |
| 99214 Office E&M - Established | Office | 312 | 185 | $99.29 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 223 | 158 | $14.02 | $3,125 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 200 | 54 | $0.72 | $143 |
| 96401 Chemotherapy Administration | Office | 186 | 23 | $65.00 | $12K |
| 96413 Chemotherapy Administration | Office | 163 | 43 | $116.49 | $19K |
| 99213 Office E&M - Established | Office | 97 | 73 | $72.41 | $7,024 |
| 96415 Chemotherapy Administration | Office | 72 | 14 | $24.90 | $1,793 |
| 20610 Joint Injection | Office | 65 | 43 | $55.44 | $3,603 |
| 99204 Office E&M - New | Office | 23 | 23 | $138.69 | $3,190 |
| 99215 Office E&M - Established | Office | 15 | 12 | $157.46 | $2,362 |
| 73130 X-ray - Upper Extremity | Office | 12 | 12 | $54.46 | $654 |
By year: 2022 $629K for 44,533 services; 2023 $604K for 50,323 services; 2024 $607K for 59,738 services.
Medicare prescription drug claims, 2024
In 2024, the drug John Vischio prescribed most often to Medicare patients was Prednisone, with 607 prescriptions and refills. In total John Vischio wrote 3,620 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 607 | 1,255 | 157 | $5,322 |
| Hydroxychloroquine Sulfate Generic | 426 | 1,138 | 118 | $12K |
| Methotrexate Methotrexate Sodium | 361 | 949 | 96 | $11K |
| Celecoxib Generic | 208 | 503 | 66 | $7,517 |
| Allopurinol Generic | 179 | 509 | 48 | $2,149 |
| Alendronate Sodium Generic | 127 | 343 | 44 | $1,141 |
| Meloxicam Generic | 125 | 291 | 48 | $679 |
| Tramadol Hcl Generic | 124 | 144 | 27 | $694 |
| Enbrel Etanercept | 116 | 134 | 13 | $1.0M |
| Leflunomide Generic | 95 | 244 | 27 | $6,490 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 74 | 74 | 11 | $1,586 |
| Leucovorin Calcium Generic | 64 | 163 | 20 | $3,247 |
| Folic Acid Generic | 61 | 168 | 18 | $823 |
| Diclofenac Sodium Generic | 55 | 112 | 16 | $1,569 |
| Colchicine Generic | 53 | 119 | 15 | $1,380 |
Brand drugs: - claims; generic drugs: 3,232 claims; opioid claims: 354.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Vischio $3,737 ($3,737 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $905.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 49 | $905 |
| Amgen Inc. AMGN | 20 | $459 |
| Janssen Biotech, Inc. JNJ | 17 | $396 |
| UCB, Inc. UCB.BR | 17 | $321 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $201 |
| Genzyme Corporation SNY | 6 | $194 |
| Mallinckrodt Hospital Products Inc. | 6 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $157 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $153 |
| Genentech USA, Inc. ROG.SW | 5 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.